Cerus Corp. (NASDAQ:CERS) saw a downside of -0.66% to close Friday at $1.50 after subtracting -$0.01 on the day. The 5-day average trading volume is 1,122,400 shares of the company’s common stock. It has gained $1.6600 in the past week and touched a new high 1 time within the past 5 days. An average of 1,081,345 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,110,236.
CERS’s 1-month performance is -14.29% or -$0.2100 on its low of $1.4650 reached on 09/21/23. The company’s shares have touched a 52-week low of $1.47 and high of $4.25, with the stock’s rally to the 52-week high happening on 01/05/23. YTD, CERS has lost -58.90% or -$2.1500 and has reached a new high 3 times. However, the current price is down -64.71% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CERS stock investors last saw insider trading activity on Aug 22.Greenman William Mariner (President and CEO) most recently sold 60,480 shares at $2.80 per share on Mar 13. This transaction cost the insider $169,344. Chief Operating Officer, Jayaraman Vivek K, sold 25,356 shares at a price of $2.80 on Mar 13. Then, on Mar 13, Chief Medical Officer Benjamin Richard J sold 25,353 shares at a price of $2.79 per share. This transaction amounted to $70,781.
Valuation Metrics
CERS stock has a beta of 1.14. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.77 while the price-to-book (PB) in the most recent quarter is 5.33.
Cerus Corp.’s quick ratio for the period ended June 29 was 1.47, with the current ratio over the same period at 2.01. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.36, while the total debt to equity was 1.73. In terms of profitability, the gross margin trailing 12 months is 55.44%. The trailing 12-month EBITDA margin is -34.43% while for the period ending June 29, Cerus Corp.’s operating margin was -46.60%. The firm’s gross profit as reported stood at $113.36 million against revenue of $188.31 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 36.82% to -$13.28 million, while revenue of -$15.62 million was -17.62% off the previous quarter. Analysts expected CERS to announce -$0.06 per share in earnings in its latest quarter, but it posted -$0.06, representing a 0.00% surprise. EBITDA for the quarter stood at more than -$11.0 million. CERS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 147.17 million, with total debt at $88.01 million. Shareholders hold equity totaling $180.8 million.
Let’s look briefly at Cerus Corp. (CERS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 September was 25.67% to suggest the stock is trending oversold, with historical volatility in this time period at 41.73%.
The stock’s 5-day moving average is $1.5440, reflecting a -7.98% or -$0.1300 change from its current price. CERS is currently trading -11.24% above its 20-day SMA, -36.17% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -40.71% and SMA200 by-62.41%.
Stochastic %K and %D was 7.25% and 6.99% and the average true range (ATR) pointed at 0.0994. The RSI (14) points at 30.00%, while the 14-day stochastic is at 8.07% with the period’s ATR at 0.1070. The stock’s 9-day MACD Oscillator is pointing at -0.0867 and -0.1150 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Cerus Corp. (NASDAQ: CERS), BTIG Research downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for CERS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate CERS as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is CERS’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $3.00 and a high of $9.00, with their median price target at $5.50. Looking at these predictions, the average price target given by analysts is for Cerus Corp. (CERS) stock is $5.75.
